Future growth stocks of 1997 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Future growth stocks of 1997

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dan Ross who wrote (41)	12/13/1996 11:55:00 PM
From: Henry Niman	of 391

Dan, There have been several interesting comments on LGND's future. Two of the leading Biotech newsletters (Medical Technology Stock Letter and California Technology Stock Letter) love LGND. Jim McCamant of MTSL put LGND in his Emerging Elite category about 1 1/2 years ago. LGND and the three others (AGPH, ARRS, and ISIP) were expected to become profitable with the next five years because of their enabling technology, alliance partners, and seasoned management). One year ago, when picking Biotechs for 1996, Jim McCamant said these companies could generate 1000% returns over 5 years. About 1 1/2 years ago, Michael Murphy of CTSL had a five year target for LGND of $100. Recently he participated in a live chat session sponsored by Worth Magazine. Among Biotechs, LGND was his #1 pick for the longer term. A few weeks later, Jim McCamant also was on a live chat session and he also liked LGND. Transcripts of both chat sessions can be found at worth.com (search Ligand - both chat sessions will come up as well as MTSL and CTSL recs). LGND was also featured in Fortunes 50th? Anniversary Issue (about 9 months ago?). They had a huge article on apoptosis (programmed cell death) and its impact on Biotechnology and Medicine (I think its at fortune.com - I know the electronic version was available on Compuserve awhile ago). LGND was mentioned as the leader in getting anti-cancer drugs to market (because its two most advanced products are retinoids which induce apoptosis and they were in advanced trials already). If readers want, I can upload any or all of these articles. Henry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next